Is adiponectin associated with acute myocardial infarction in Iranian non obese patients?
The present study showed that adiponectin was associated with AMI in non obese patients but it is not related to sex, age and other CAD risk factors.
Pretreatment s-VEGF level is a predictor of PFS after chemoimmunotherapy and may help to further stratify high-risk DLBCL patients into low- and high-risk groups.